Table 4.
Observed cellular superoxide dismutase (SOD) activity in cells after 72 h of treatment. Data are presented as mean ± standard error of the mean. Significant differences are indicated by different letters (uppercase letters within row; lowercase letter within column for each treatment option) according to Tukey post hoc test (p < 0.05): control (no treatment); human skeletal muscle myoblast (HSMM); diabetic human skeletal muscle myoblast (DHSMM).
| Metformin (μM) | K. pinnata (μg/mL) | HSMM SOD Activity (U/mg of Protein/min) |
Stress-Induced SOD Activity (U/mg of Protein/min) | DHSMM SOD Activity (U/mg of Protein/min) |
|---|---|---|---|---|
| Control (0) | Control (0) | 60.48 ± 4.68 Aa | 57.68 ± 7.63 Aa | 40.35 ± 10.95 Aa |
| 5000 | 0 | 137.81 ±15.80 Ab | 77.89 ± 12.31 Bb | 65.91 ± 11.48 Bb |
| 0 | 400 | 71.90 ± 12.94 Ac | 83.89 ± 17.68 Ab | 59.92 ± 14.63 Ac |
| 200 | 25 | 68.91 ± 3.34 Ac | 59.92 ± 17.30 Aa | 44.94 ± 14.31 Aa |
| 150 | 50 | 59.92 ± 6.40 Aa | 56.92 ± 11.83 Aa | 59.92 ± 12.06 Ac |
| 100 | 100 | 86.88 ± 10.91 ABd | 107.85 ± 24.48 Ac | 59.92 ± 14.35 Bc |
| 50 | 150 | 62.91 ± 5.57 Aa | 56.92 ± 8.04 Aa | 56.92 ± 13.16 Ac |
| 30 | 200 | 68.91 ± 9.12 Ac | 59.92 ± 13.68 Aa | 47.93 ± 6.61 Aa |
| 10 | 300 | 71.9 ± 6.97 Ac | 59.92 ± 12.06 Aa | 56.92 ± 10.20 Ac |